On-Demand Webinars
-
Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics
11/6/2024
Unlock the potential of antibody-drug conjugates (ADCs) by exploring our novel payloads, designed for easy access and evaluation, to accelerate your ADC drug development with proven efficacy and safety.
-
From iPSCs To Functional NK Cell Therapy - A Client Journey
10/30/2024
Discover how iPSC-based allogeneic cell therapies, guided by Cellistic's top experts and powered by Pulse and Echo platforms, are set to transform healthcare.
-
Regulatory Considerations Including Extractables & Leachables For Single-Use Manufacturing
10/29/2024
Watch to gain insights into regulatory guidance for single-use manufacturing and risk assessment strategies for single-use implementation.
-
How To Plan For Trouble-Free Filter Validation
10/28/2024
Watch to learn when filter validation should be performed, what is required from an end user and laboratory testing perspective, and how to achieve first-time success for various drug products.
-
Reducing Risks By Outsourcing OSD Manufacturing And Packaging
10/23/2024
Watch to discover the key benefits of outsourcing your OSD production and explore real-world examples and best practices to help you streamline your processes and enhance your operational agility.
-
Accelerating Nasal Dosage Form Development From Early-Phase To Clinical Trial Manufacture
10/21/2024
Led by Dr. Richard Johnson, Chief Scientific Officer, this 40-minute session covers the five key stages of the UpperNose development platform, highlighting the significance of target product selection and its influence on formulation and clinical outcomes.
-
Use Of Spray Drying In Pharmaceutical Product Development
10/21/2024
Through this detailed exploration, participants will gain valuable knowledge on how to leverage spray drying to optimize drug development and delivery.
-
Achieving Manufacturing Efficiency In OSD Manufacturing
10/16/2024
Gain expert insight into the importance of instrumented tablet presses in assessing formulation properties, the role of tablet cup configurations, and scalability parameters for successful product transfer.
-
Breaking Barriers: Combining Cell Line Development Innovation With Improved Process Development Workflows To Streamline Path To FIH
10/16/2024
Explore how KBI Biopharma’s SUREtechnology Platform™, powered by Selexis®, accelerates the development of complex biologics from early stages to first-in-human (FIH) trials, focusing on both speed and quality.
-
The Road To Approval: Viral Clearance Strategies For Non-Enveloped Viral Vectors
10/10/2024
Know the differences between designing a viral clearance study for non-enveloped viral vectors versus those for mAbs or recombinant proteins, and learn how to identify and remove viral contaminants.